Delivery Order SPE2DB22D2206-SPE2DB25FJA10
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $55,560.43 for BIKTARVY 50-200-25 mg tablets (30-count units) by the Defense Logistics Agency on September 9, 2025. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 10, 2025, with performance taking place at the company's Conshohocken facility. The award represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,288.90 by the Defense Logistics Agency for BIKTARVY 30-120-15 mg tablets (30-count supply). The contract, awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,635.27, is set to be completed by August 13, 2025, and represents performance at the company's Conshohocken facility. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $36,245.57 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive, firm fixed-price delivery order was placed under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) valued at $56,371.98 under a firm fixed price contract type. The award, made on June 26, 2025, with an ultimate completion date of June 27, 2025, represents a non-competitive delivery order utilizing an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, by the Defense Logistics Agency for $50,225.55 to supply Biktarvy 50-200-25 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 8, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,733.66 for BIKTARVY 50-200-25 30S on August 15, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania and is scheduled for completion by September 12, 2025. The contract is funded through the Medical Supply Chain, a defense-oriented federal...
- The Defense Logistics Agency awarded a $46,648.39 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with a completion date of June 17, 2025, and represents a non-set-aside award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a $14.76K delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) under a firm fixed-price contract, with an ultimate completion date of September 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award involved no set-aside designation,...
- The Defense Logistics Agency awarded a $159,128.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA10Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,715.77 by the Defense Logistics Agency on July 22, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract contains no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. The company maintains a substantial prime indefinite delivery vehicle valued at $999,999,999.00 through December 2026, which enables the delivery of a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs globally. This delivery order for BIKTARVY, an antiretroviral medication, exemplifies the company's ongoing role as a major vendor fulfilling federal pharmaceutical supply requirements through open competition.